RO5190591 ritonavir-boosted danoprevir

ritonavir-boosted danoprevir; danoprevir boosted with ritonavir · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO5190591 ritonavir-boosted danoprevir, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1 [Phase 1]

See pricing